HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A controlled double-blind study comparing binedaline and imipramine in the treatment of endogenous depression.

AbstractUNLABELLED:
50 hospitalized endogenously depressed patients (age 20-60 years, HAM-D greater than or equal to 18) were treated daily with 3 X 50 mg imipramine or 3 X 100 mg binedaline. Clinical and laboratory assessments were done before and on days 1, 3, 5, 15 and 30 of treatment. Mean Hamilton and Zung scores were statistically significant lower on day 30 when compared with pretreatment scores. No psychiatric, clinical or statistical differences were noted between the two groups. The efficacy of the clinical global impression scale was slightly higher in the binedaline groups. Frequency of side effects (specially anticholinergic) was lower in the binedaline group.
CONCLUSION:
binedaline is equally effective as imipramine, but with less side effects.
AuthorsF Faltus, F C Geerling
JournalNeuropsychobiology (Neuropsychobiology) Vol. 12 Issue 1 Pg. 34-8 ( 1984) ISSN: 0302-282X [Print] Switzerland
PMID6239991 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antidepressive Agents
  • Indoles
  • binedaline
  • Imipramine
Topics
  • Adult
  • Antidepressive Agents (therapeutic use)
  • Depressive Disorder (drug therapy)
  • Double-Blind Method
  • Drug Eruptions (etiology)
  • Female
  • Humans
  • Imipramine (adverse effects, therapeutic use)
  • Indoles (adverse effects, therapeutic use)
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: